LOX and diabetes mellitus: Data presented here, performed in C57BL6 mice, osteoblasts, and MC3T3‐E1 cells, identify a novel gut/bone metabolic relationship that regulates osteoblast LOX that is dysregulated in diabetes, and importantly is amenable to therapeutic intervention.